New Anlon Healthcare IPO: Key Details, Strengths, and Insights

The Anlon Healthcare IPO will open on 26th August 2025 and close on 29th August 2025. The IPO price band is fixed at ₹86 – ₹91 per share, making it accessible for a wide base of investors.

The minimum investment required is ₹14,104 for 164 shares (1 lot), while the issue size stands at ₹121.03 crore. The tentative allotment date is 1st September 2025, and the listing date is expected on 3rd September 2025.

---

Also Read: Vikran Engineering IPO

---

About the Company

Founded in 2013 and led by Mr. Punitkumar R. Rasedia, Anlon Healthcare is a chemical manufacturing company that specializes in high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs).

The company also produces nutraceutical APIs and ingredients for personal care and veterinary health products. Importantly, its APIs comply with both Indian and international pharmacopeia standards, making it a recognized player in the global healthcare supply chain.

---

Product Portfolio and Services

Anlon Healthcare’s diverse portfolio includes:

• Pharmaceutical intermediates – raw materials for API production
• APIs and nutraceutical APIs – used in tablets, capsules, ointments, syrups, and nutraceuticals
• Personal care and veterinary ingredients – catering to global healthcare needs

This wide range ensures the company is not reliant on a single product line, improving stability.

---

Strengths of Anlon Healthcare

• Strong International Approvals: The company has received DMF (Drug Master File) approvals from regulators in Brazil, USA, China, and India, and has filed 21 DMFs globally.
• Wide Product Pipeline: Currently has 65 commercialized products, 28 at the pilot stage, and 49 under laboratory-scale testing.
• Global Clientele: Supplies to more than 15 countries, including the USA, Germany, South Korea, UK, and Japan.
• Strong Manufacturing Capabilities: Two dedicated blocks for intermediates and APIs with a capacity of 400 million tonnes per annum.

---

---

Financial Performance Overview

• Revenue: ₹112.88 Cr (FY23) → ₹66.58 Cr (FY24) → ₹120.29 Cr (FY25)
• PAT (Profit After Tax): ₹5.82 Cr (FY23) → ₹9.66 Cr (FY24) → ₹20.52 Cr (FY25)
• Assets: Expanded in line with production needs

This shows consistent profitability and expansion, though FY24 revenue saw a dip before rebounding strongly in FY25.

---

Opportunities in the Healthcare Sector

• Global Demand for APIs: Rising pharmaceutical outsourcing provides growth opportunities.
• Nutraceutical Growth: Increasing demand for wellness and preventive care products.
• Compliance Advantage: ISO certifications and GMP approvals enhance credibility worldwide.

---

Risks and Concerns

Investors should also note:

• Regulatory Dependency: Heavy reliance on approvals and compliance across global jurisdictions.
• Competitive Market: Faces strong competition from established global API producers.
• Operational Challenges: Manufacturing complexities and quality assurance demands can affect margins.

---

Subscription and Allotment Details

• Retail Investors: Can apply up to ₹2,00,000.
• High Net-Worth Individuals (HNIs): Can apply between ₹2,00,000 and ₹5,00,000.
• Allotment Date: 1st September 2025
• Listing Date: 3rd September 2025

---

Expert Insights on Anlon Healthcare IPO

Analysts believe the Anlon Healthcare IPO offers strong potential due to its global approvals, diversified portfolio, and rising profitability. However, the competitive landscape and regulatory challenges mean it is best suited for long-term investors who can withstand short-term fluctuations.

---

Who Should Invest?

• Retail Investors: Looking for exposure to the growing pharmaceutical and healthcare industry.
• HNIs: Interested in possible listing gains along with long-term value creation.
• Long-Term Growth Seekers: Those who want to invest in a globally active healthcare company.

---

FAQs About Anlon Healthcare IPO

Q1. What is the issue size of Anlon Healthcare IPO?
A1. ₹121.03 crore.

Q2. What is the IPO price band?
A2. ₹86 – ₹91 per share.

Q3. What is the minimum investment?
A3. ₹14,104 for one lot (164 shares).

Q4. When does the IPO open and close?
A4. Opens on 26th August 2025 and closes on 29th August 2025.

Q5. When will it be listed?
A5. Tentatively on 3rd September 2025.

---

The Anlon Healthcare IPO represents a promising opportunity in the fast-expanding pharmaceutical and healthcare space. With strong DMF approvals, a diversified product line, and consistent profit growth, the company is well-positioned for future expansion.

---

**Disclaimer: However, always review your risk appetite and portfolio mix before committing.**

**Disclaimer: The Image in the article is taken from google is used for article which is generated by Chatgpt content. always review your risk appetite and portfolio mix before committing. We are not Finanacial advisors this content is our own analysis and any loss or gains are not subjected to our mention opinon. Invest at your own risk**

---